Introduction
Benign prostatic hyperplasia (BPH) assigns most of men after the age of fifty and represents the most common urologic disease among elderly males 1 . BPH is histologically defined as an overgrowth of the epithelial and stromal cells from the transition zone and peri-urethral area.
Incidence of histological BPH could be over 70% at 60 years old and over 90% at 70 years old 2 .
But histological BPH doesn't systematically lead to clinical manifestations. BPH symptoms can range over a wide scale from minimal bother to urinary retention and renal failure. To date, we
still have no precise knowledge of the cellular and molecular processes underlying the pathogenesis of BPH and leading to a symptomatic disease 3 . Although the influence of androgens and estrogens has been demonstrated, hormonal factors alone may not fully explain BPH development.
There are some evidences that prostatic inflammation could be a key component in prostate enlargement and BPH progression.
Two of the major clinical studies on BPH (MTOPS and
Reduce study) recently demonstrated a link between histological prostatic inflammation and prostate enlargement or symptoms scores 4, 5 . Numerous of the major key players in chronic inflammation have been studied in BPH: varieties of growth factors and cytokines have been shown to be involved both in the inflammatory process and in the epithelial/stromal prostatic cells interactions 6 . These mediators are released in the prostatic gland by inflammatory cells that can be found on most of the surgery-derived BPH specimens 7 .
Our aim was to characterize inflammatory cells infiltrate within BPH tissue and to correlate inflammation and clinical parameters in order to evaluate the BPH progression/complication risks in patients with prostatic inflammation.
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Material and methods
BPH Samples
Inflammation .
Scoring of inflammation
Six cytological parameters were evaluated on TMAs including the type of immune cells (lymphocytes, macrophages and polynuclears leukocytes) and three modifications of glandular aspect: glandular atrophy, glandular destruction and tissue fibrosis. Modifications of glandular aspect were studied because they are known to be associated with chronic inflammatory process 9 .
Cytological and IHC parameters were separately quoted by two independent observers including one senior uropathologist (GR, YA). The presence or absence of macrophages, polynuclears leukocytes, atrophy, destruction, and fibrosis, was quoted using binary scores (0/1). The presence of lymphocytes and other IHC markers was quoted as absent, low, or high (0/1/2).
When a difference was noticed between the two independent scores a third analysis was performed and was taken into account for the statistical analysis.
Statistical analysis
Individual patient's inflammation score was obtained from assessing the maximal grade of all valid cores from the same patient. At least one valid core per patient was required.
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Then, the 6 individual cytological grading (lymphocyte, macrophages, polynuclears leukocytes, atrophy, destruction, and fibrosis) were computed to make a "cytological score". The five individual IHC grading (CD3, CD4, CD8, CD20, CD163) were computed to make an "IHC score".
Cytological and IHC scores were compared to clinical data using a non parametric correlation test, the Kendalls'tau-b test. Commercially available software was used for statistical analyses (SPSS inc., Chicago, Il.).
Results Seven cases on the TMA were not assessed because there was no valid core on TMAs.
Inflammation was measured in the remaining 275 patients with a mean valid core per patient of 3.5.
Composition of the BPH inflammatory infiltrate
As shown on Figure 1 , BPH inflammatory infiltrate was mostly constituted by T-lymphocytes (CD3 positive cells). T-lymphocytes were more frequently observed than other inflammatory cells: two third had CD8 expression and one third had CD4 expression. 
Association between inflammation and clinical data
Clinical data was compared between patients with low and high grade inflammation ( 
Discussion

Inflammatory cells infiltrate in BPH tissue
We studied inflammation cells infiltrate in a large cohort of BPH patients requiring surgical treatment. Using cytological analysis and IHC inflammation markers, we characterized the inflammation cells infiltrate.
Most of surgery-derived BPH specimens are known to contain inflammatory infiltrates at pathological examination 7, 10 . According to Theyer et al works, prostatic inflammatory infiltrate may be composed of a majority of T-lymphocytes (up to 70%) and of about 30% antigenpresenting cells (15% B-lymphocytes and 15% macrophages) 11 . They also found that the CD4/CD8 ratio in BPH samples was reversed compared with normal prostate and stated that
CD4-lymphocytes (memory T-helper cells) may represent up to 60% of T-cells infiltrate in BPH
tissues. More recently Di Carlo et al described in detail the composition of the prostate-associated lymphoid tissue in normal prostate 12 . They found that it was containing two main components:
one with a majority of T-lymphocytes infiltrating the peri-glandular area, with up to 70% CD8 cells, and another one with lymphoid aggregates lying in the fibro-muscular stroma with B-lymphocyte follicules representing 50% of the hole aggregate surrounded by parafollicular T-lymphocytes with about twice as much CD4 than CD8 cells.
In our cohort, almost 80% of patients had a significant T-lymphocyte infiltrate with a predominance of CD8 expression. T-lymphocytes were more numerous than other inflammatory cells and were representing the major part of the inflammatory infiltrate observed in the prostatic gland. To build the TMA, four cores per patients were performed including 2 from predominantly glandular zone and 2 from stromal area. Thus, glandular and stromal areas are equally represented on the TMA which is not reflecting usual glandular/stromal ratio in the BPH transition zone. This might be an explanation for the unusual CD8/CD4 ratio in our study: CD8 cells are more frequently observed in the peri-glandular area and in the normal prostate tissue than in the lymphoid aggregates. When focusing on lymphoid aggregates observed on TMA cores, we also found a higher rate of CD4 cells (cf. figure 1, patient 3) .
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Smaller amounts of B-cells and macrophages were observed in respectively 52% and 82% of patients. Macrophages and B-lymphocytes are antigen-presenting cells that play a role in the first step of the inane inflammatory response. They may be stimulated directly by infectious agents or by prostatic epithelial cells themselves 6 . Then, numerous cytokines and growth factors involved in the inflammatory response (IL-17, IFN-γ, TGF-β, FGF-2…) are secreted and stimulate growth of epithelial and stromal prostatic cells 13, 14 . This immune response against possible infectious agents finally results in prostatic enlargement.
CD3 is expressed by any type of T-lymphocytes. Lymphocyte infiltrate quantification was almost similar using cytological examination method, and IHC method with CD3 marker (77% and 79%, respectively). In contrary, macrophage infiltrates was found much higher using an IHC method with CD 163 marker than with a cytological way (82% versus 44%).
Since they were present in 5% of patients only, polynuclear leukocytes might not play an important role in BPH development. Significant glandular changes such as atrophy, destruction and fibrosis were observed in a minority of cases. It is known that in the transition zone chronic cellular infiltrates are often associated with glandular atrophy. Once again, our TMA was build with equal number of glandular and stromal cores and we didn't analyse the entire BPH transition zone. This is an explanation for the lower quality of the glandular architecture analysis in this study. Nonetheless, the statistical analysis highlighted an interesting link between glandular atrophy and T-lymphocyte infiltration of the prostatic gland (p<0.01). Therefore, we can suppose that chronic BPH inflammation might lead to significant glandular architecture changes.
BPH inflammation and clinical data
Prostate volume is known to have a real impact on BPH: baseline prostate size can be considered as a strong indicator of BPH progression, particularly for acute urinary retention and BPH-related surgery but also for long-term changes in symptoms, bother, quality of life, and flow Authors were reporting 45% chronic inflammation and 3% acute inflammation in a large cohort of BPH patients (n=1197) treated with 5-ARI. They found an association between prostatic inflammation and higher prostate volume (41.1 vs 36.8cc; p= 0.0002), higher risk of urinary retention (5.6% vs 0%; p=0.003) or higher risk of symptomatic evolution (21% vs 13.2%; p=0.083). More recently these results were confirmed by the Reduce study It is quite surprising that half of patients operated for a diagnosis purpose had high grade prostatic inflammation while they had no LUTS (table 4) . This is probably due to the fact that most inserm-00440934, version 1 -14 Dec 2009 of them had undergone at least 2 previous biopsy series before TURP which may have induced inflammation within the prostate.
Contrarily to MTOPS and Reduce studies, no association between BPH inflammation and urinary retention risk was found. This may be explained by the fact that the population we studied was different from the ones of other studies. Indeed, except 31 cases operated for a diagnosis purpose, patients included in our IHC analysis had symptomatic or complicated disease requiring surgical treatment. In MTOPS and reduce studies, patients had BPH symptoms not requiring surgical treatment.
Inflammation as a target for medical therapy
As prostatic inflammation is associated to prostate volume, it might be a therapeutic target in In our study, no association was found with the type of medical therapy applied to the patient and severity of prostatic inflammation. As almost all patients included in our analysis required surgery, medical therapy they were receiving can be considered as inefficient. At this stage of the disease, inflammatory process may not be controlled by any medical therapy. Same treatment given to patients with a less severe disease not requiring surgery may modify inflammation infiltrate within BPH tissue.
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Conclusion
Inflammatory cell infiltrate was evaluated in a large cohort of surgically treated BPH patients. CD8
T-lymphocytes and macrophages infiltrate were present in more than 80% of cases. The role of inflammation in BPH development was highlighted by the strong correlation between histological inflammation and IPSS or prostate volume. Prostate enlargement due to chronic inflammatory process may progressively conduce to BPH progression. Therefore, some drugs with antiinflammatory effects could be used in the management of BPH.
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